Article
Bone Marrow T Cell Changes By Multiplex IHC after Treatment with Flotetuzumab, a CD123 x CD3 Bispecific Dart® Protein, in a Primary Refractory t-AML Patient
Blood
(2018)
Disciplines
Publication Date
November 29, 2018
DOI
10.1182/BLOOD-2018-99-118522
Citation Information
John Godwin, Carmen Ballesteros-Merino, Carlo B Bifulco, Helene Lelièvre, et al.. "Bone Marrow T Cell Changes By Multiplex IHC after Treatment with Flotetuzumab, a CD123 x CD3 Bispecific Dart® Protein, in a Primary Refractory t-AML Patient" Blood Vol. 132 (2018) p. 4065 - 4065 Available at: http://works.bepress.com/carlo-bifulco/70/